...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Calcineurin and m-TOR Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-II Study

【24h】

Calcineurin and m-TOR Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-II Study

机译：钙调磷酸酶和无m-TOR抑制剂的移植后环磷酰胺（PTC）和硼替佐米（B）联合用于预防移植物抗宿主病（GvHD）：I-II期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共1页
作者
Al-Homsi A. Samer; Cole Kelli; Muilenburg Marlee; Duffner Ulrich; Abidi Muneer H.; Williams Stephanie F.; Mageed Aly A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Calcineurin and m-TOR Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-II Study [J] . Al-Homsi A. Samer, Cole Kelli, Muilenburg Marlee, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：钙调磷酸酶和无m-TOR抑制剂的移植后环磷酰胺（PTC）和硼替佐米（B）联合用于预防移植物抗宿主病（GvHD）：I-II期研究
2. Calcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study [J] . Al-Homsi A. Samer, Cole Kelli, Muilenburg Marlee, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2017,第10期

机译：钙皮林和MTOR抑制剂的移植后后移植后环磷酰胺和硼齐佐米的组合用于移植物 - 与宿主疾病预防后外周血异种造血干细胞移植术后：I / II期研究
3. Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study [J] . Al-Homsi Ahmad-Samer, Cole Kelli, Bogema Marlee, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第7期

机译：异基因外周血干细胞移植后移植环磷酰胺和硼替佐米预防移植物抗宿主病的短期疗程是可行的，并产生良好的结果：I期研究
4. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
5. Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity [O] . Kai Sun, Danice E. C. Wilkins, Miriam R. Anver, -1

机译：硼替佐米抑制蛋白酶体对小鼠急性移植物抗宿主病（GVHD）的不同作用：硼替佐米的延迟给药导致GVHD依赖性胃肠道毒性增加
6. Calcineurin and m-TOR Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-II Study [O] . A. Samer Al-Homsi, Kelli Cole, Marlee Muilenburg, 2016

机译：钙皮林和M-TOR抑制剂的移植后环磷酰胺（PTC）和硼替佐米（B）组合预防移植物与宿主疾病（GVHD）：II-II研究
7. Prevention of Canine Graft-versus-Host Disease (GVHD) [R] . Storb, R. 1986

机译：预防犬移植物抗宿主病（GVHD）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号